Our findings are highly relevant for cancer therapeutic strategies, and suggest that treatments reliant on ROS will be more effective in tumor cells with high levels of STING expression whereas therapies that do not rely upon ROS generation for their efficacy may be more relevant in the setting of STING loss. Here, STING1 is linked to neoplasm.